Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53

Abstract Background The current guidelines in Sweden regarding individuals with a clinically actionable (i.e. pathogenic or likely pathogenic) germline TP53 variant recommend patients to take part of the national Swedish P53 Study (SWEP53). Methods The study comprises a patient registry (mandatory f...

Full description

Bibliographic Details
Main Authors: Meis Omran, Lennart Blomqvist, Yvonne Brandberg, Niklas Pal, Per Kogner, Anne Kinhult Ståhlbom, Emma Tham, Svetlana Bajalica-Lagercrantz
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Hereditary Cancer in Clinical Practice
Subjects:
LiFraumeni syndrome
Germline TP53 mutation
Hereditary breast cancer
Pathological variant
Surveillance program
Online Access:https://doi.org/10.1186/s13053-020-0133-5

Internet

https://doi.org/10.1186/s13053-020-0133-5

Similar Items